EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF NRL/LP/201901 CAPSULES AS ADJUVANT THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Dr. Omkar Kulkarni*, Dr. Anuj Agarwal, Priya Khare, Gayatri Ganu and Dr. Medha Kulkarni

ABSTRACT

Background: Diabetes is swiftly gaining the status of a potential epidemic in India with more than 62 million diabetic individuals currently diagnosed with the disease. Herbal supplements target the different pathological events from different mechanistic approaches, to manage glucose homeostasis and to improve the quality of life of the patient. Aim: The aim of the study was to evaluate the efficacy and safety of NRL/LP/201901 capsules in type 2 diabetic patients. Materials and Methods: A randomized double blind, placebo controlled, comparative, interventional, multi-centric, prospective clinical Study was conducted. Subjects were advised to take a dose of 1 capsule orally after evening/night meal with water for 90 days. Following parameters were assessed during study- Fasting Plasma Glucose (FPG), 2-hr Post-Meal Glucose (PMG), Haemoglobin A1c (HbA1c), Fasting Insulin (FI) and 2-hr Post-Meal Insulin (PMI), b-cell functions by [HOMA]-b, insulin resistance (IR) by HOMA-IR, anthropometric measurements from baseline to end of visit. Results: 100 subjects completed the study. It was evident that NRL/LP/201901 capsules significantly reduced fasting and post meal glucose levels along with HbA1c, there was significant reduction in insulin resistance evident by HOMA IR score. The quality of life in patients was improved in NRL/LP/201901 capsule treated group. It also improved lipid profile and anthropometric parameters which may be helpful in preventing CVS complications in diabetes mellitus. C - reactive protein (CRP) levels were significantly reduced after treatment of test drug. Conclusion: Thus “NRL/LP/201901” capsule is safe and effective medicine as an adjuvant for the treatment of Diabetes type 2.

Keywords: Diabetes mellitus type2, HbA1c, Fasting insulin, herbal, CRP.

[Full Text Article] [Download Certificate]